Michael King
Stock Analyst at EF Hutton
(0)
# 4780
Out of 5,273 analysts
132
Total ratings
28.70%
Success rate
-23.91%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Apollomics | Maintains: Buy | 1100 650 | 6.5 | 9900% | 4 | Apr 1, 2024 | |
Sonnet BioTherapeuti... | Assumes: Buy | 1180 | 1.44 | 81788.89% | 7 | Aug 23, 2023 | |
Lantern Pharma | Reiterates: Buy | 11 | 3.9 | 182.05% | 10 | Aug 10, 2023 | |
Biomea Fusion | Reiterates: Buy | 32 | 2.77 | 1055.23% | 11 | Jun 26, 2023 | |
Jasper Therapeutics | Reiterates: Buy | 69 | 5.5 | 1145.45% | 10 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 200 | n/a | n/a | 7 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 9 | 1.18 | 603.39% | 6 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 862 | 680.88 | 26.6% | 11 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 38.51 | -37.68% | 10 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 17 | 0.08 | 21150% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 166 | 2.56 | 6384.38% | 7 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 42 | 14.23 | 195.15% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 304 | 243.04 | 25.08% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 123 116 | 9.37 | 1137.99% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | 2.79 | 269.18% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 560 | 0.8 | 69900% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 37.27 | -35.61% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1000 800 | 1.01 | 79107.92% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 46 | 15.34 | 199.87% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 98 96 | 33.44 | 187.08% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10500 5250 | n/a | n/a | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 0.86 | 4086.05% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.48 | 2400% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 31 | 7.2 | 330.56% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | n/a | n/a | 1 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 180 160 | 0.08 | 199900% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 1088 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 33 36 | 623.67 | -94.23% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 38 | n/a | n/a | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 29, 2017 |